Page 129 - Avian Virology: Current Research and Future Trends
P. 129

122  |  Brown and Eterradossi

          protein successfully replicate in vitro and in vivo (Biacchesi et al.,   fusion the ribonucleoprotein complex (RNP) made up of the N,
          2004b; Naylor et al., 2004) showing that F has both attachment   P and L proteins containing the viral RNA (vRNA) is released
          and fusion properties. It has been suggested for human Metap-  into the cell cytoplasm for transcription of mRNA or to serve
          neumoviruses that the interaction of F with target cells involves   as template for complementary RNA (cRNA) and subsequent
          the integrin binding domain RGD with an integrin αvβ1 receptor.   vRNA  production.  After  the  synthesis  of  vRNA  and  proteins,
          It is unknown if similar interactions occur for the avian viruses   the M protein and RNPs are transported directly to the cell
          however, no RGD binding domain has been identified in the F   membrane. The glycoproteins F, SH and G pass through the
          proteins of AMPVs. The F protein is also highly immunogenic and   endoplasmic reticulum (ER) to the Golgi apparatus and then to
          contains  important  epitopes  for  protective  immune  responses   the plasma membrane. Here all the components are assembled,
          (Brown et al., 2009; Hu et al., 2017).                and new virions are released by a budding process.
            Of all the viral proteins, the functional role of SH remains the   A recent study looking  at the late stages of the HMPV
          most elusive. Several groups have demonstrated that it is dispen-  virus replication  cycle showed that not all subsequent
          sable for AMPV, HMPV and RSV viability though its deletion   infections result from the budding/attachment mechanism
          does result in some level of attenuation. SH-deleted AMPVs also   described above. In this study a new role for the P protein
          have an altered cytopathic effect in vitro (Ling et al., 1992; Naylor   was  observed as it  interacted with  the actin cytoskeleton in
          et al., 2004). Recently the SH protein of HMPV has been shown   human bronchia airway cells leading to extensive branched
          to inhibit and down-regulate certain processes in different cellular   networks between cells where viruses and or just RNPs were
          signalling pathways (Bao et al., 2008a; Hastings et al., 2016). It has   transmitted (Fig. 4.4) without ever passing via the extra cel-
          also been recently reported that like the SH of RSV, the HMPV   lular environment (El Najjar et al., 2016). As cited in that
          SH forms oligomeric structures in the target cell membrane   paper cell-to-cell spread independent of particle release has
          making the membrane more permeable (Masante et al., 2014).   also been reported for the closely related RSV, measles virus,
          For AMPV more studies are required concerning the functional   influenza A virus and parainfluenza virus 5 (Shigeta et al.,
          roles of this small hydrophobic protein.              1968; McQuaid et al., 1998; Lawrence et al., 2000; Makhor-
            Finally, the surface G protein, which is the most variable MPV   tova et al., 2007; Roberts et al., 2015; Singh et al., 2015). A
          protein in terms of amino acid sequence, is considered responsi-  mini review dedicated to these mechanisms has also recently
          ble for virus attachment to cells however; as discussed above it is   been published (Mothes et al., 2010).
          now clear that it is not the only protein capable of carrying out
          this process. Similar to the F protein it is highly immunogenic and
          contains  important  epitopes  for  protective  immune  responses   Reverse genetics
          (Hu et al., 2017; Naylor et al., 2007). Similar to the SH protein   ‘Reverse genetics’, as the term implies, is the opposite of ‘regular
          it is also emerging as an inhibitor of cellular immune responses   genetics’. In brief, regular genetics looks at the genetic basis of
          (Bao et al., 2008b, 2013; Kolli et al., 2011).        a phenotype whereas reverse genetics looks at phenotypes that
                                                                arise from specific changes introduced into genetic sequences. In
                                                                virology, reverse genetics systems allow the rescue of infectious
          Viral replication                                     viruses that carry precise genome sequences from cloned cDNA
          Most of the current understanding for the AMPV replication   so as to study their phenotypic effect.
          cycle is based on that of other negative-sense single-stranded   The first reverse genetics (RG) system that allowed the rescue
          RNA viruses, above all HRSV. AMPV replication takes place in   of infectious AMPV from cloned cDNA was reported in 2004
          the cytoplasm of infected cells. Firstly, the virus attaches to the   (Naylor et al., 2004). In the same year RG systems were developed
          surface of target cells, the process of which is mainly directed   for HMPV (Biacchesi et al., 2004a; Herfst et al., 2004). RG sys-
          by the surface glycoprotein G, for RSV this involves binding to   tems were then subsequently developed for AMPV-C (US turkey
          glycosaminoglycans especially heparin sulphate and chondroitin   strain) (Govindarajan et al., 2006), AMPV-B (Laconi et al., 2016)
          sulfate B (Collins and Karron, 2013) however it is now clear   and most recently for AMPV-C (EU duck strain) (Szerman et al.,
          that the fusion protein also plays a part in this process (Ling et   2018). Although varied methods were used to construct these
          al., 2008; Cseke et al., 2009; Wei et al., 2014). After attachment   systems, all are based on the co-transfection of plasmids encoding
          of MPVs to the target cell, the F protein promotes fusion of the   the proteins of the RNP complex plus M2 and the viral genome
          viral envelope and the plasma membrane. The factor triggering   either  in  the  negative  or  positive  sense.  Interestingly  all  these
          fusion remains unclear though it has been suggested, at least for   systems have been placed under the control of a T7 promoter
          HMPV, that it could be the result of the binding to integrin αvβ1   sequence for which the T7 polymerase has either been delivered
          (Schildgen et al., 2011). This seems unlikely for AMPVs as the   using helper viruses or by cell lines that are maintained to consti-
          conserved αvβ1 integrin binding motif of RGD of the F protein   tutively express it by antibiotic selection. None have been based
          of HMPVs (Cox et al., 2012) is not present in any of the known   on the eukaryotic pCMV promoter which would seem an easier
          AMPV F protein sequences. These have been reported to be RSD   option as it would eliminate the need for helper viruses and put
          for all AMPV C viruses and RDD for AMPV-A, B and D (Brown   less restriction on the cell type required for rescue. Furthermore,
          et al., 2014).                                        a dual plasmid system with one plasmid encoding the genome
            As previously reviewed (Schildgen et al., 2011), following   and the other all four support proteins, similar to that described
   124   125   126   127   128   129   130   131   132   133   134